Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 2:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 13,471 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Endocrine Disorders Clear all

Conditions: Serious Mental Illness, Type 2 Diabetes
Interventions: MetSense Risk Flag, Usual Care; Behavioral · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 20,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Pleasanton, California

Conditions: Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma, Thromboembolism, Vaginal Cancer, Vulvar Cancer
Interventions: fondaparinux sodium; Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years and older · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Upland, Pennsylvania

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: SGLT-2 inhibitor (Sotagliflozin), Insulin withdrawal test (IWT); Drug · Other
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 18 Years to 40 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Precursors to PCOS
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 8 Years to 12 Years · Female only
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer Female, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Endometrial Cancer, Gynecologic Cancer
Interventions: Not listed
Lead sponsor: George Washington University; Other
Eligibility: 21 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Diabetes, Pregnancy
Interventions: Minimum intervention control group, Treatment for glucose intolerance; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: San Jose, California • Stanford, California

Conditions: Pancreas Adenocarcinoma, Dysplasia
Interventions: LINFU™; Diagnostic Test
Lead sponsor: Adenocyte, LLC; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Sarasota, Florida

Conditions: Diabetic Foot, Diabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown
Interventions: Real Time Continuous Glucose Monitoring (rt-CGM), Fingerstick blood glucose (FBG) monitoring, Diabetes Education; Device · Other · Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Atlanta, Georgia • Decatur, Georgia

Conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
Interventions: D4064A; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 2
States / cities: New York, New York • Nashville, Tennessee

Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer
Interventions: chemotherapy, paclitaxel; Drug
Lead sponsor: Gynecologic Oncology Group; Network
Eligibility: 21 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 5
States / cities: Orange, California • Chicago, Illinois • Indianapolis, Indiana + 2 more

Conditions: Type 1 Diabetes
Interventions: REAL-Fam Occupational Therapy Family Coaching; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 2 Years to 99 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Diabetes, Diabetes Mellitus, Infected Wound, Infected Ulcer of Skin
Interventions: Phototherapy, Debridement Surgery and Wound Dressing; Device · Procedure
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Body Weight
Interventions: DGA Mediterranean diet pattern, energy balance, DGA Mediterranean diet pattern, negative energy balance, TAD diet pattern, negative energy balance; Other
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 19 Years to 64 Years · Female only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Davis, California

Conditions: Ovarian Cancer, Solid Tumor
Interventions: CUSP06; Drug
Lead sponsor: OnCusp Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 14
States / cities: Denver, Colorado • New Haven, Connecticut • Miami Beach, Florida + 9 more

Conditions: Congenital Adrenal Hyperplasia, CAH - Congenital Adrenal Hyperplasia
Interventions: SPR001; Drug
Lead sponsor: Spruce Biosciences; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 9
States / cities: Orange, California • San Diego, California • Melbourne, Florida + 6 more

Conditions: Type 2 Diabetes
Interventions: Standard of Care, Shared Medical Appointments; Other · Behavioral
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 12 Years to 18 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • San Francisco, California

Conditions: Type 2 Diabetes
Interventions: BT-001, Physician-guided Standard of Care for type 2 diabetes; Device · Other
Lead sponsor: Better Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 668 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 6
States / cities: San Francisco, California • Miami, Florida • Atlanta, Georgia + 3 more

Conditions: Polycystic Ovary Syndrome
Interventions: Not listed
Lead sponsor: Georgia Reproductive Specialists; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Lower Limb Amputation Below Knee, Diabetes (DM), Skin Temperature Change, Vascular Reactivity
Interventions: Warming stimulus starting at 30 C initial temperature, Warming stimulus starting at 32 C initial temperature, Warming stimulus starting at 34 C initial temperature, Warming stimulus starting at 35 C initial temperature, Cooling stimulus starting at 30 C initial temperature, Cooling stimulus starting at 32 C initial temperature, Cooling stimulus starting at 34 C initial temperature, Cooling stimulus starting at 35 C initial temperature; Other
Lead sponsor: VA Puget Sound Health Care System; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Diabetes
Interventions: CareAvenue, Guest Assistance Program; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 75 Years
Enrollment: 667 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Diabetes
Interventions: TExT-MED, FANS; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetes
Interventions: Regular insulin (intensive treatment), Regular Insulin (conventional treatment); Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 338 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetes Mellitus
Interventions: Case Management; Other
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Obesity, Type 2 Diabetes
Interventions: No intervention planned.; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 99 Years
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

MetSense Pilot and Feasibility

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors

Research Study for Children With a Mother or Sister With Polycystic Ovary Syndrome

Diet, Hepcidin, and Chemotherapy RDI

Early Screening and Treatment of Women With Prediabetes in Pregnancy

A Proof-of-Concept Study Evaluating LINFU™

CGM and DFU Healing Post-discharge

A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

REAL-Fam Feasibility Study for Youth Diabetes Management

Adjunctive Phototherapy Treatment of Infected Diabetic Ulcers

Metabolic and Bio-behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia

Implementation of Team Clinic for Type 2 Diabetes (TCT2)

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

The Impact of Polycystic Ovary Syndrome (PCOS) on Quality of Life and Healthcare Beliefs

Skin Temperature Perception and Prosthetic Thermoregulation

Diabetes Outcomes and Unmet Resources

TExT-MED + FANS Full Trial

Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery

Effect of Care Management on Diabetes Outcomes

Role of Pancreatic Triglyceride Content in Beta-cell Function